A phase i study of intralymphatic (il) administration of ipilimumab (ipi) with intravenous nivolumab (nivo) using the sofusa (r) doseconnect t device in patients with advanced melanoma

Anastasios Dimou,Vera Suman, Kristina Denic, Lisa Kottschade,Heather Montane, Heidi Finnes, Kristina Franta,Jill Schimke,Yiyi Yan,Robert McWilliams,Matthew Block, James Jakub,Joel Reid,Svetomir Markovic

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要